A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints-Reference-Cited by-同舟云学术

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints

Published:2012-06 Issue:6 Volume:13 Page:e240-e248
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Fumagalli Debora,Bedard Philippe L,Nahleh Zeina,Michiels Stefan,Sotiriou Christos,Loi Sherene,Sparano Joseph A,Ellis Matthew,Hylton Nola,Zujewski Jo Anne,Hudis Clifford,Esserman Laura,Piccart Martine

Publisher

Elsevier BV

Subject

Oncology

Reference73 articles.

1. Multimodal treatment for locally advanced breast cancer: result of chemotherapy-radiotherapy versus chemotherapy-surgery;De Lena;Cancer Clinical Trials,1981

2. Primary chemotherapy in operable breast cancer: eight year experience of the Milan Cancer Institute;Bonadonna;J Clin Oncol,1998

3. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

4. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902;van der Hage;J Clin Oncol,2001

5. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel;Smith;J Clin Oncol,2002

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review;European Journal of Surgical Oncology;2024-10

2. Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project;BMJ Open;2024-04

3. Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?;Indian Journal of Surgical Oncology;2023-09-29

4. Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP;Journal of Clinical Oncology;2023-09-20

5. Variation in Endpoints in FDA Medication Approvals;Neurology;2023-09-05